Dr. Zhongping Chen's lab focuses on creating advanced imaging technologies for better understanding and detecting coronary artery disease (CAD). The research aims to develop a sophisticated imaging system that combines different modalities to assess the vulnerability of atherosclerotic plaques. By using this technology, the lab hopes to enhance clinical management and treatment customization for patients with heart disease.

Dr. Charles G. Glabe's lab at UC Irvine focuses on understanding the formation and dynamics of amyloid plaques, a key feature of Alzheimer's disease. The research aims to investigate how different types of amyloid deposits are formed by various cell types and their roles in the progression of the disease. By using innovative labeling techniques to track proteins in real-time, the lab hopes to uncover new insights that could guide the development of better therapies for Alzheimer's.

Dr. Christopher Vanderwal's lab focuses on developing new treatments for malaria and babesiosis, both caused by parasites. The lab investigates a compound derived from leelamine that shows promise against these diseases. The goal is to create effective drugs that can combat resistant strains of the parasites and assess their safety and mechanisms of action.

Dr. Rongsheng Jin's lab at UC Irvine focuses on understanding a type of bacterial toxin known as botulinum neurotoxins (BoNTs), which can cause a serious illness called botulism. The lab is particularly interested in a specific complex associated with these toxins, aiming to explore its structure and how it functions in order to develop new treatments for botulism and similar bacterial infections. They utilize advanced techniques to study how these toxins interact with proteins and receptors in the body, ultimately helping improve public health.

Dr. Anna Grosberg's lab at UC Irvine focuses on understanding how obstructive sleep apnea (OSA) affects heart and blood vessel health. By combining clinical data with advanced tissue engineering techniques, the lab aims to explore the mechanisms linking OSA to cardiovascular diseases. This research seeks to develop better diagnostic tools and treatment strategies for patients suffering from OSA and associated cardiovascular complications.

Dr. Robert F. Hunt's lab at UC Irvine focuses on understanding the role of chromatin regulators in neurodevelopmental disorders like epilepsy and autism. The team studies how genetic mutations affect brain development and function, aiming to discover new treatment approaches. By using advanced techniques in genetics, cell biology, and electrophysiology, they explore how to manipulate gene expression to potentially develop targeted therapies.

Dr. Stephen Schueller's research lab at UC Irvine focuses on improving mental health care access for Spanish-speaking Latinx patients living in resource-limited settings. They are developing and assessing digital cognitive-behavioral therapy interventions that can be implemented in primary care clinics, aiming to reduce disparities in mental health services. The lab emphasizes the importance of peer support in these digital interventions to enhance engagement and effectiveness among underrepresented populations.

Dr. Minji Byun's lab at UC Irvine focuses on understanding how mutations in the DNMT3A gene, particularly common in older adults, affect inflammation and increase the risk for diseases like cancer and heart disease. The lab uses advanced human cell models to explore the molecular mechanisms linking these mutations to altered immune responses. Their goal is to uncover insights that could lead to new treatments for diseases associated with DNMT3A mutations.

Dr. Yongsheng Shi's lab at UC Irvine focuses on understanding the processes that control how genes are expressed at the molecular level, particularly through mechanisms called alternative polyadenylation (APA) and alternative splicing. The research is particularly interested in how these processes affect B cell development and function, which are critical for the immune response. By uncovering the regulatory networks involved, the lab aims to provide insights that could lead to improved treatments for autoimmune diseases and cancer.

Dr. Elizabeth Head's research focuses on Alzheimer's disease and how to potentially slow its progression using specific medications. Her lab studies the effects of a drug called tacrolimus in aging beagle dogs, which can show signs of cognitive decline similar to humans. By measuring cognitive outcomes, biological markers, and brain health, the goal is to understand if targeting a specific pathway in the brain can serve as a new treatment strategy for Alzheimer's in humans.

Dr. Kei M. Igarashi's lab at UC Irvine specializes in understanding the brain circuits involved in memory formation and retrieval, particularly in the context of Alzheimer's disease. The lab conducts research on the lateral entorhinal cortex, which plays a crucial role in these cognitive functions. By using advanced techniques such as optogenetics and transgenic mouse models, the lab aims to identify the specific neuronal types impacted by Alzheimer's to develop potential treatments for memory impairments.

Dr. Brian Paegel's lab focuses on developing innovative technologies for drug discovery by utilizing DNA-encoded libraries. They aim to create more effective methods to identify drug candidates that can target challenging protein interfaces, a vital step in the quest for new therapies. By employing advanced techniques like microfluidics and automated processes, the lab seeks to make drug discovery more accessible and efficient, potentially revolutionizing how new treatments are developed for various diseases.

Dr. Anthony A. James' lab at UC Irvine focuses on developing innovative genetic strategies to combat malaria, a disease that significantly impacts global health. They are particularly interested in using gene-drive systems, which harness CRISPR technology, to alter the reproductive capabilities of malaria-carrying mosquitoes, thereby reducing their populations and spreading resistance to the malaria parasite. The lab's work aims to provide new tools that are effective, safe for humans and the environment, and resilient against reinvasion by susceptible mosquito populations.

Dr. Albert R. La Spada's lab at UC Irvine focuses on understanding neurodegenerative diseases, particularly those caused by abnormal protein expansions known as polyglutamines, such as spinal and bulbar muscular atrophy and Huntington's disease. The research aims to uncover cellular mechanisms that lead to motor neuron degeneration and explore potential therapeutic strategies to restore cellular balance in neurodegenerative conditions. By investigating the roles of specific proteins and pathways, the lab seeks to develop drugs to mitigate neurotoxicity and promote neuronal health.

Devon A. Lawson's lab at the University of California-Irvine focuses on understanding the role of immune cells in brain metastasis, particularly in breast cancer. The lab investigates how brain resident macrophages called microglia can affect tumor growth and immune responses within the central nervous system. Their research aims to uncover mechanisms that could lead to new immunotherapeutic strategies for treating metastatic breast cancer patients.

Dr. David C. Lyon's lab at UC Irvine focuses on advancing treatments for vision loss due to retinal degeneration diseases like age-related macular degeneration and retinitis pigmentosa. The research explores the use of retinal progenitor tissue transplants to restore vision by investigating how these transplants integrate into the visual system and influence higher-level visual processing in the brain. The ultimate aim is to improve vision among patients who have lost significant retinal tissue.

Dr. Francesco Marangoni's lab at UC Irvine focuses on understanding how certain cancer treatments, specifically checkpoint blockade immunotherapy, can sometimes fail due to the body's immunosuppressive responses. By studying the role of immune cells called T regulatory cells and how different tumor environments affect them, the lab aims to identify strategies to enhance the effectiveness of these therapies. Their ultimate goal is to improve cancer treatment options for patients who currently see little benefit from existing therapies.

Dr. Selma Masri's research lab focuses on understanding how disruptions in our body's internal clock, known as the circadian clock, can influence the development of colorectal cancer, particularly in younger adults. The lab investigates how these disruptions impact cellular changes in the intestine, metabolism, and immune responses that may contribute to cancer progression. Through innovative mouse models and patient-derived samples, the lab aims to identify new prevention and treatment strategies for colorectal cancer.

Dr. Bin Nan's lab at UC Irvine focuses on developing statistical methods to improve research on Alzheimer's disease and aging. The lab works on methodologies for analyzing complex data from cohort studies, particularly for underrepresented populations. By creating new predictive models and statistical software, the lab aims to enhance our understanding of Alzheimer's etiology, prevalence, and prevention strategies.

The lab of Eric Olaf Potma at UC Irvine focuses on developing advanced biosensing techniques that allow for the rapid detection of individual molecules without the need for labels. By combining innovative optical methods with engineered nanostructures, the research aims to enhance the speed and specificity of molecular identification, particularly in DNA analysis. This work has the potential to revolutionize fields such as genomics and diagnostics by enabling quicker and more accurate assessments of genetic material.